Skip to content

The mechanism of infrapatellar fat pad in the occurrence and development of osteoarthritis

The mechanism of infrapatellar fat pad in the occurrence and development of osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064806
Enrollment
Unknown
Registered
2022-10-19
Start date
2022-10-19
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis (OA)

Interventions

Healthy control group:N/A
Late OA group:N/A

Sponsors

The Third Affiliated Hospital of Anhui Medical University (The First People's Hospital of Hefei)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Blood samples were taken from 160 patients undergoing total knee replacement or anterior cruciate ligament ruptured reconstruction and repair under general anesthesia, including 40 patients with subpatellar fat pads and other soft tissues. 2. All patients were confirmed as advanced OA by surgery, imaging or histopathology; all patients were confirmed as advanced OA by two independent orthopedic/pathologic surgeons' review of surgery, imaging or histopathology results; all patients had not received radiotherapy, chemotherapy, targeted therapy or other immunotherapy; Patients with anterior cruciate ligament rupture reconstruction and repair surgery were included as the normal healthy group. 3. Patients with past medical history, present medical history, personal history and postoperative pathological and environmental data are complete, and voluntarily sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Diagnosed with other types of musculoskeletal diseases, such as osteomyelitis and peripheral nerve injury and other motor system injuries; 2. Have had or are suffering from other types and sites of joint diseases, such as rheumatoid arthritis, gouty arthritis, traumatic arthritis; History of meniscectomy; 3. History of knee joint trauma; 4. Other rheumatic immune diseases such as ankylosing spondylitis, sclerosclerosis myositis and Sjogren's syndrome; Previous treatment history of radiotherapy, chemotherapy, targeted therapy and other immunotherapy; 5. Abnormal liver and kidney function; 6. History of neurological diseases, etc.

Design outcomes

Primary

MeasureTime frame
changes of histomorphology of the infrapatellar fat pad;inflammatory cell infiltration;inflammatory factor levels;Retinol-binding protein 4;

Countries

China

Contacts

Public ContactNing Rende

The Third Affiliated Hospital of Anhui Medical University (The First People's Hospital of Hefei)

1301535636@qq.com+86 139 5696 6305

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026